MedPath

KAMEDIS LTD.

🇮🇱Israel
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:1

Trial Phases

3 Phases

Phase 2:1
Phase 4:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (33.3%)
Phase 2
1 (33.3%)
Phase 4
1 (33.3%)

Safety and Efficacy of SEBORRHEAMEDIS Face Cream in Patients With Seborrheic Dermatitis

Not Applicable
Completed
Conditions
Seborrheic Dermatitis
First Posted Date
2016-01-14
Last Posted Date
2016-01-14
Lead Sponsor
Kamedis Ltd.
Target Recruit Count
30
Registration Number
NCT02656368

Clinical Study to Evaluate Safety and Efficacy of KAM1403 Gel to Treat Radiation Dermatitis

Phase 2
Conditions
Radiation Dermatitis
First Posted Date
2014-01-31
Last Posted Date
2014-01-31
Lead Sponsor
Kamedis Ltd.
Target Recruit Count
60
Registration Number
NCT02051907
Locations
🇮🇱

Sourasky Medical Center, Tel Aviv, Israel

Efficacy of KAM2904 Face Cream and KAM3008 Body Lotion Treatment in Children With Atopic Dermatitis (AD)

Phase 4
Conditions
Atopic Dermatitis
First Posted Date
2013-02-01
Last Posted Date
2014-01-30
Lead Sponsor
Kamedis Ltd.
Target Recruit Count
56
Registration Number
NCT01781663
Locations
🇪🇸

Fundación Teknon, Barcelona, Spain

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.